Albert Cha (L) and Jamie Brush (Frazier)
A pair of partners at Frazier is following early-stage biotechs to the public market with an $830M fund. And they're already doing deals
Just a few days ago, the executive team at San Diego-based Crinetics $CRNX announced that it is spawning a newborn biotech which 5AM helped …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
